Premium Nahrungsergänzungsmittel | artgerecht

Optic Neuritis: Causes, Symptoms and Treatment

Optic neuritis is an inflammation of the optic nerve that typically causes sudden vision loss and eye pain. It is often associated with multiple sclerosis.

Regular tips about health Regular tips about health

Things worth knowing about "Optic neuritis"

Optic neuritis is an inflammation of the optic nerve that typically causes sudden vision loss and eye pain. It is often associated with multiple sclerosis.

What is Optic Neuritis?

Optic neuritis is an inflammation of the optic nerve, the nerve that transmits visual information from the eye to the brain. The condition typically leads to a sudden loss or deterioration of vision, most commonly affecting one eye at a time. It most frequently affects young adults between the ages of 20 and 40, and is more common in women than in men.

Causes

Optic neuritis is most often an autoimmune condition in which the immune system mistakenly attacks the myelin sheath surrounding the optic nerve. Common causes and associated conditions include:

Multiple sclerosis (MS): The most frequent cause. Optic neuritis is often the first symptom of MS.
Neuromyelitis optica spectrum disorder (NMOSD): An autoimmune condition affecting both the optic nerve and the spinal cord.
Viral or bacterial infections: Such as measles, mumps, chickenpox, or Lyme disease.
Systemic autoimmune diseases: Including lupus erythematosus or sarcoidosis.
Idiopathic optic neuritis: With no identifiable underlying cause.

Symptoms

Symptoms of optic neuritis usually develop over hours to days and typically affect only one eye:

Sudden vision loss or blurred vision (often progressing over hours to days)
Eye pain, especially with eye movement
Color vision disturbances, particularly reduced red-green perception
Visual field defects (known as scotomas)
Dimness or graying of vision
Uhthoff phenomenon: Temporary worsening of vision with body heat (e.g., during exercise or hot showers)

Diagnosis

Diagnosis of optic neuritis is based on a combination of clinical examination and diagnostic tests:

Ophthalmological examination: Visual acuity test, visual field measurement (perimetry), color vision test, and fundoscopy
Pupillary response: A relative afferent pupillary defect (RAPD) is a hallmark sign of optic neuritis
Visual evoked potentials (VEP): Measuring the electrical conductivity of the optic nerve
MRI (magnetic resonance imaging): Detecting demyelinating lesions in the optic nerve and brain, essential for MS evaluation
Blood tests: To rule out other causes (e.g., AQP4 antibodies in suspected NMOSD)
Lumbar puncture: Cerebrospinal fluid analysis when multiple sclerosis is suspected

Treatment

Treatment of optic neuritis depends on the severity of symptoms and any underlying condition:

Corticosteroid Therapy

High-dose corticosteroids (e.g., intravenous methylprednisolone) are commonly used to speed up visual recovery. This treatment shortens the duration of vision loss but has not been shown to improve long-term visual outcomes.

Treatment of Underlying Conditions

In cases of underlying multiple sclerosis or NMOSD, long-term immunomodulatory or immunosuppressive therapy is required to prevent further relapses and protect the optic nerve from additional damage.

Prognosis

In most cases, vision recovers substantially within weeks to months. However, some patients experience residual symptoms such as persistent color vision deficits or mild visual impairment. Recurrent episodes increase the risk of permanent optic nerve damage.

When to See a Doctor?

Sudden vision loss, eye pain, or disturbances in color vision require immediate medical attention. Early diagnosis and prompt treatment are critical to preserving vision and identifying any serious underlying neurological condition.

References

Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83-99. PubMed PMID: 24331795.
Optic Neuritis Study Group. Visual function 15 years after optic neuritis. Ophthalmology. 2008;115(6):1079-1082. PubMed PMID: 18164066.
Wingerchuk DM, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-189. PubMed PMID: 26092914.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.